vs
ASURE SOFTWARE INC（ASUR）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
ASURE SOFTWARE INC的季度营收约是STANDARD BIOTOOLS INC.的1.9倍（$36.3M vs $19.6M），ASURE SOFTWARE INC净利率更高（-14.8% vs -177.4%，领先162.6%），ASURE SOFTWARE INC同比增速更快（23.7% vs -11.5%），ASURE SOFTWARE INC自由现金流更多（$5.7M vs $-23.1M），过去两年ASURE SOFTWARE INC的营收复合增速更高（11.2% vs -12.2%）
Asure Software是一家软件企业，其前身为Forgent Networks，2007年9月完成品牌更名后，业务逐渐拓展至人力资本管理领域，为客户提供薪资发放、考勤管理、人才管理、人力资源管理、福利管理以及保险相关服务等解决方案。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
ASUR vs LAB — 直观对比
营收规模更大
ASUR
是对方的1.9倍
$19.6M
营收增速更快
ASUR
高出35.2%
-11.5%
净利率更高
ASUR
高出162.6%
-177.4%
自由现金流更多
ASUR
多$28.7M
$-23.1M
两年增速更快
ASUR
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $36.3M | $19.6M |
| 净利润 | $-5.4M | $-34.7M |
| 毛利率 | 63.8% | 48.5% |
| 营业利润率 | -9.7% | -168.5% |
| 净利率 | -14.8% | -177.4% |
| 营收同比 | 23.7% | -11.5% |
| 净利润同比 | -37.5% | -28.8% |
| 每股收益（稀释后） | $-0.19 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASURLAB
| Q3 25 | $36.3M | $19.6M | ||
| Q2 25 | $30.1M | $21.8M | ||
| Q1 25 | $34.9M | $40.8M | ||
| Q3 24 | $29.3M | $22.1M | ||
| Q2 24 | $28.0M | $22.5M | ||
| Q1 24 | $31.7M | $45.5M | ||
| Q4 23 | $26.3M | $28.2M | ||
| Q3 23 | $29.3M | $25.4M |
净利润ASURLAB
| Q3 25 | $-5.4M | $-34.7M | ||
| Q2 25 | $-6.1M | $-33.5M | ||
| Q1 25 | $-2.4M | $-26.0M | ||
| Q3 24 | $-3.9M | $-26.9M | ||
| Q2 24 | $-4.4M | $-45.7M | ||
| Q1 24 | $-308.0K | $-32.2M | ||
| Q4 23 | $-3.6M | $-19.8M | ||
| Q3 23 | $-2.2M | $-21.0M |
毛利率ASURLAB
| Q3 25 | 63.8% | 48.5% | ||
| Q2 25 | 66.1% | 48.8% | ||
| Q1 25 | 70.6% | 48.4% | ||
| Q3 24 | 67.2% | 54.9% | ||
| Q2 24 | 67.3% | 46.1% | ||
| Q1 24 | 71.4% | 53.1% | ||
| Q4 23 | 67.9% | 47.6% | ||
| Q3 23 | 72.5% | 44.0% |
营业利润率ASURLAB
| Q3 25 | -9.7% | -168.5% | ||
| Q2 25 | -15.4% | -118.1% | ||
| Q1 25 | -5.8% | -80.8% | ||
| Q3 24 | -12.4% | -120.9% | ||
| Q2 24 | -14.9% | -134.5% | ||
| Q1 24 | -1.4% | -132.2% | ||
| Q4 23 | -14.3% | -75.9% | ||
| Q3 23 | 0.9% | -83.5% |
净利率ASURLAB
| Q3 25 | -14.8% | -177.4% | ||
| Q2 25 | -20.3% | -153.7% | ||
| Q1 25 | -6.9% | -63.8% | ||
| Q3 24 | -13.3% | -122.0% | ||
| Q2 24 | -15.5% | -203.3% | ||
| Q1 24 | -1.0% | -70.6% | ||
| Q4 23 | -13.6% | -70.2% | ||
| Q3 23 | -7.5% | -82.8% |
每股收益（稀释后）ASURLAB
| Q3 25 | $-0.19 | $-0.09 | ||
| Q2 25 | $-0.22 | $-0.09 | ||
| Q1 25 | $-0.09 | $-0.07 | ||
| Q3 24 | $-0.15 | $-0.07 | ||
| Q2 24 | $-0.17 | $-0.12 | ||
| Q1 24 | $-0.01 | $-0.27 | ||
| Q4 23 | $-0.16 | $-0.24 | ||
| Q3 23 | $-0.10 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $21.5M | $129.4M |
| 总债务越低越好 | $70.4M | — |
| 股东权益账面价值 | $193.1M | $399.7M |
| 总资产 | $447.1M | $539.6M |
| 负债/权益比越低杠杆越低 | 0.36× | — |
8季度趋势，按日历期对齐
现金及短期投资ASURLAB
| Q3 25 | $21.5M | $129.4M | ||
| Q2 25 | $66.0M | $158.6M | ||
| Q1 25 | $14.1M | $150.9M | ||
| Q3 24 | $11.2M | $210.6M | ||
| Q2 24 | $20.7M | $269.8M | ||
| Q1 24 | $23.2M | $287.1M | ||
| Q4 23 | $30.3M | $51.7M | ||
| Q3 23 | $32.8M | $79.7M |
总债务ASURLAB
| Q3 25 | $70.4M | — | ||
| Q2 25 | $67.4M | — | ||
| Q1 25 | $14.1M | — | ||
| Q3 24 | $7.5M | $55.2M | ||
| Q2 24 | $6.0M | $55.1M | ||
| Q1 24 | $5.3M | $55.0M | ||
| Q4 23 | $4.3M | $63.5M | ||
| Q3 23 | $2.8M | $64.6M |
股东权益ASURLAB
| Q3 25 | $193.1M | $399.7M | ||
| Q2 25 | $194.3M | $424.5M | ||
| Q1 25 | $197.7M | $454.6M | ||
| Q3 24 | $199.2M | $489.3M | ||
| Q2 24 | $195.5M | $510.3M | ||
| Q1 24 | $197.7M | $577.3M | ||
| Q4 23 | $191.7M | $-148.1M | ||
| Q3 23 | $191.7M | $-131.7M |
总资产ASURLAB
| Q3 25 | $447.1M | $539.6M | ||
| Q2 25 | $505.6M | $557.0M | ||
| Q1 25 | $498.9M | $579.6M | ||
| Q3 24 | $428.1M | $681.5M | ||
| Q2 24 | $420.1M | $708.7M | ||
| Q1 24 | $469.3M | $777.7M | ||
| Q4 23 | $443.9M | $323.1M | ||
| Q3 23 | $394.5M | $339.3M |
负债/权益比ASURLAB
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.07× | — | ||
| Q3 24 | 0.04× | 0.11× | ||
| Q2 24 | 0.03× | 0.11× | ||
| Q1 24 | 0.03× | 0.10× | ||
| Q4 23 | 0.02× | — | ||
| Q3 23 | 0.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.8M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $5.7M | $-23.1M |
| 自由现金流率自由现金流/营收 | 15.6% | -118.1% |
| 资本支出强度资本支出/营收 | 0.3% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $11.6M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流ASURLAB
| Q3 25 | $5.8M | $-22.2M | ||
| Q2 25 | $3.2M | $-20.7M | ||
| Q1 25 | $2.0M | $-30.3M | ||
| Q3 24 | $1.3M | $-27.9M | ||
| Q2 24 | $2.2M | $-39.0M | ||
| Q1 24 | $-3.9M | $-62.5M | ||
| Q4 23 | $7.1M | $-14.1M | ||
| Q3 23 | $5.7M | $-11.4M |
自由现金流ASURLAB
| Q3 25 | $5.7M | $-23.1M | ||
| Q2 25 | $3.0M | $-22.6M | ||
| Q1 25 | $1.8M | $-35.3M | ||
| Q3 24 | $1.2M | $-30.1M | ||
| Q2 24 | $2.1M | $-41.0M | ||
| Q1 24 | $-4.2M | $-63.3M | ||
| Q4 23 | $6.8M | $-14.1M | ||
| Q3 23 | $5.4M | $-12.3M |
自由现金流率ASURLAB
| Q3 25 | 15.6% | -118.1% | ||
| Q2 25 | 9.8% | -103.6% | ||
| Q1 25 | 5.2% | -86.6% | ||
| Q3 24 | 3.9% | -136.4% | ||
| Q2 24 | 7.5% | -182.2% | ||
| Q1 24 | -13.2% | -138.9% | ||
| Q4 23 | 26.1% | -50.2% | ||
| Q3 23 | 18.4% | -48.6% |
资本支出强度ASURLAB
| Q3 25 | 0.3% | 4.5% | ||
| Q2 25 | 0.7% | 8.7% | ||
| Q1 25 | 0.6% | 12.4% | ||
| Q3 24 | 0.6% | 10.2% | ||
| Q2 24 | 0.5% | 8.6% | ||
| Q1 24 | 0.8% | 1.7% | ||
| Q4 23 | 0.8% | 0.3% | ||
| Q3 23 | 1.2% | 3.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASUR
| Recurring | $31.8M | 88% |
| Lathem Time | $4.6M | 13% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
